Clinical trials
Dementia clinical trials
Below are recruiting dementia clinical trials, each written for real people, not researchers. We’re tracking 492 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07577440Recruiting
Mental Health Support Program for Dementia Caregivers
This study tests whether a mental health support program helps informal caregivers of people with dementia feel better emotionally and mentally. You'll learn skills to improve your wellbeing while caring for a loved one with dementia.
PortoAges 18 years+ - NCT07618481Recruiting
Brain Stimulation Study for Alzheimer's Disease
This study tests whether a special type of brain stimulation called 40Hz BCI (brain-computer interface) might help slow memory loss in people with Alzheimer's disease. You would receive daily stimulation sessions at home with help from a caregiver.
Shanghai, Shanghai MunicipalityAges 50–80 - NCT07626944Recruiting
Music and Sound Therapy for Dementia Behaviors
This study tests whether special music and sound patterns can help reduce difficult behaviors and improve mood in people with dementia living in assisted care. Researchers will play these sounds to you and track any changes in how you feel and behave.
Denver, ColoradoAges 55–95 - NCT07634055Recruiting
Motor Reserve in Early Dementia Stages
This study compares how the brain controls movement in people with mild memory loss (MCI) versus healthy people. Researchers want to understand how the brain compensates early on, which could help identify who might develop dementia.
Catanzaro, CatanzaroAges 18–85 - NCT07646782Recruiting
Human Observatory Study: Aging and Longevity Research
This study observes how people age over time to better understand what helps people live longer and healthier lives. You'll share health information through surveys or online screening, and researchers will track changes in your health and wellbeing.
Boulder, ColoradoAges 18 years+ - NCT07651319RecruitingPhase 1/Phase 2
IL-2 and Semaglutide Treatment for Alzheimer's Disease
This study tests whether two drugs—IL-2 (an immune-boosting medication) and semaglutide (a diabetes drug that may help brain function)—can slow memory loss in people with Alzheimer's disease. Researchers believe these drugs together might help reduce brain inflammation and protect memory.
Houston, TexasAges 50–86 - NCT07667478Recruiting
Brain stimulation study for early Alzheimer's memory loss
This study tests whether a non-invasive magnetic brain stimulation technique can help improve memory in people with early Alzheimer's disease. It may be an option if you have mild cognitive impairment or mild dementia due to Alzheimer's and have had a positive blood test for Alzheimer's markers.
Houston, TexasAges 55–90 - NCT07594665Enrolling by invitation
Home-based cognitive health blood tests for older adults
This study invites people aged 65+ who are already part of the SHUTi MIND research program to do simple blood tests at home to check for early signs of cognitive changes. The goal is to make it easier for people to access brain-health testing without going to a clinic.
Charlottesville, VirginiaAges 65 years+ - NCT07567664Enrolling by invitation
Brain Changes in Neurodegenerative Diseases: A Tracking Study
This research study tracks how brain damage progresses in rare neurodegenerative diseases like frontotemporal dementia, primary progressive aphasia, PSP, CBS, and ALS. Researchers use brain imaging and tests to understand how these diseases spread in the brain, which could help develop better treatments.
Milan, LombardyAges 20–85 - NCT07521384Enrolling by invitation
Real-World Study of Intranasal Cell Therapy for Brain Injuries
This study follows people who receive intranasal stem cell or exosome therapy (tiny packages from special cells) for brain or neurological conditions like stroke, brain injury, or cerebral palsy. Researchers track how well the treatment works by measuring inflammation markers in the blood and monitoring clinical improvements over time.
Monterrey, Nuevo LeónAges 4–80 - NCT07234851Enrolling by invitation
Brain tissue study of synaptic loss in mental and brain diseases
This study looks at how brain connections break down in people with psychiatric disorders (like schizophrenia, depression, or bipolar disorder) or neurodegenerative diseases (like Alzheimer's or frontotemporal dementia). It uses donated brain tissue after death to understand why symptoms occur.
BarcelonaAges 40 years+ - NCT07222449Enrolling by invitation
Wearable devices and blood tests for sleep in Alzheimer's
This study uses wrist monitors and blood tests to understand sleep problems in people with Alzheimer's dementia. It aims to improve sleep management through digital therapy and personalized insights.
Beigang, YunlinAges Any age - NCT07049341Enrolling by invitation
A pilot trial of the MemorEM device for neurological diseases
This trial tests a device called MemorEM to see how patients with neurological diseases like Alzheimer's or Parkinson's experience it. It aims to understand if the device is comfortable and easy to use.
Tampa, FloridaAges 45–100 - NCT06972004Enrolling by invitation
Preventing loss of independence through exercise for veterans
This study tests a gentle exercise program for veterans living in VA community living centers. The program is designed to help residents with memory problems stay independent, move better, and feel better. Staff at the center will be trained to lead the classes.
San Francisco, CaliforniaAges 18 years+ - NCT06940687Enrolling by invitation
Live Music Benefits for Early Alzheimer's Patients and Caregivers
This study tests whether listening to live music can improve brain function and well-being for people with early Alzheimer's or mild dementia, and their caregivers. You and your loved one would wear sensors to measure brain and heart activity during music sessions.
New Haven, ConnecticutAges 50–80 - NCT06875739Enrolling by invitation
Saliva test for early diagnosis of brain diseases
This study tests whether a saliva sample can help tell the difference between brain diseases like Alzheimer's, Parkinson's, and related conditions. By using a special laser technique, researchers hope to find a quick, non-invasive way to make an earlier and more accurate diagnosis.
CagliariAges 60–85 - NCT06860828Enrolling by invitation
Football players and brain health study: DIAGNOSE CTE
This study looks at brain changes in former college and professional football players, people with memory problems, and healthy controls. It aims to learn more about chronic traumatic encephalopathy (CTE) and Alzheimer's disease.
Phoenix, ArizonaAges 50 years+ - NCT06809725Enrolling by invitation
Study of a headband device for cognitive health check
This study tests a new way to check cognitive (thinking and memory) health using a simple headband that measures electrical signals on your scalp. It is looking for people 65 to 90 years old, with or without memory concerns, and a family member or friend who can also take part.
Miami, FloridaAges 65–90 - NCT06745011Enrolling by invitation
Parkinson's signs in people with nerve damage
This study looks for early signs of Parkinson's disease in people who have nerve damage in their hands and feet (polyneuropathy) with no known cause, along with drops in blood pressure when standing up. It aims to understand if these early symptoms might predict future Parkinson's.
Aarhus, JutlandAges 18–85 - NCT06723015Enrolling by invitationPhase 2
Tau PET in anti-amyloid therapy for Alzheimer's
This study uses brain scans to see how anti-amyloid treatments affect tau protein buildup in people with early Alzheimer's. If you have mild cognitive impairment or mild Alzheimer's, you may be eligible to help understand how these treatments work.
Rochester, MinnesotaAges 50–90 - NCT06649084Enrolling by invitation
Language treatment study for primary progressive aphasia
This study tests a multi-component language treatment for people with primary progressive aphasia (a type of dementia that first affects language). It aims to help improve communication skills with support from a study partner.
Austin, TexasAges Any age - NCT06570109Enrolling by invitation
Risk and outcomes of frailty in Alzheimer's dementia
This study looks at how frailty affects people newly diagnosed with Alzheimer's dementia. It aims to understand risk factors and outcomes to help improve care.
AalborgAges 65 years+ - NCT06533878Enrolling by invitationPhase 1
Safety of HY209 in healthy volunteers
This study tests the safety and tolerability of a new medication called HY209 in healthy volunteers. It helps researchers understand how the drug affects the body and if it causes any side effects.
Anyang-si, Gyeonggi-doAges 19–45 - NCT06431659Enrolling by invitation
Palliative care guide study at nursing homes
This study tests a guide to improve palliative care for nursing home residents. It focuses on making sure their wishes are respected and they receive appropriate support.
Stockholm, Region StockholmAges 65–130
Hear when a new Dementia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for dementia?
- Yes. Clin2 currently lists 492 recruiting dementia studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a dementia trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a dementia trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.